Individual and combined effects of selective cyclooxygenase-2 inhibitor and omega-3 fatty acid on endotoxin-induced periodontitis in rats

Journal of Periodontology

Volumn 76, Issue 1, 2005, Pages 99-106

  Vardar, Saynur ^a   Buduneli, Eralp ^a   Baylas, Haluk ^a   Berdeli, Afig Hüseyinov ^a   Buduneli, Nurcan ^a   Atilla, Gül ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Alveolar bone loss; Animal studies; Cyclooxygenase inhibitors; Fatty acids, omega 3; Gingiva physiology; Leukotriene B4; Periodontitis therapy; Platelet activating factor; Prostaglandin E2; Prostaglandin F2

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; ESCHERICHIA COLI ENDOTOXIN; LEUKOTRIENE B4; MEMBRANE PHOSPHOLIPID; OMEGA 3 FATTY ACID; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; SODIUM CHLORIDE; THROMBOCYTE ACTIVATING FACTOR;

ALVEOLAR BONE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; DRUG RESPONSE; ENZYME IMMUNOASSAY; GINGIVA; MALE; MORPHOMETRICS; NONHUMAN; OSTEOLYSIS; PERIODONTITIS; PROTEIN LOCALIZATION; RADIOIMMUNOASSAY; RAT; RAT STRAIN; STATISTICAL ANALYSIS; TISSUE DISTRIBUTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; DINOPROST; DINOPROSTONE; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ENDOTOXINS; FATTY ACIDS, OMEGA-3; LEUKOTRIENE B4; MALE; PERIODONTITIS; PLATELET ACTIVATING FACTOR; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; SULFONAMIDES;

EID: 15944384238     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2005.76.1.99     Document Type: Article

References (42)

1. Offenbacher S, Soskolne WA, Collins JG. Prostaglandins and other eicosanoids in gingival crevicular fluid as markers of periodontal disease activity. In: Johnson NW, ed. Risk Markers for Oral Diseases Vol. 3, Periodontal Disease. London: Cambridge University Press; 1991:313-338.
2. Abramson MM, Wolf LF, Offenbacher S, Aeppli DM, Hardie ND, Friedman HM. Flurbiprofen effect on gingival crevicular fluid prostaglandin and tromboxane levels in humans. J Periodontal Res 1992;27:539-543.
3. Offenbacher S, Williams RC, Jeffcoat MK, et al. Effects of NSAIDs on beagle crevicular cyclooxygenase metabolites and periodontal bone loss. J Periodontal Res 1992; 27:207-213.
4. Jeffcoat MK, Reddy MS, Haigh S, et al. A comparison of topical ketorolac, systemic flurbiprofen, and placebo for the inhibition of bone loss in adult periodontitis. J Periodontol 1995; 66:329-338.
5. Simon LS. Role and regulation of cyclooxygenase-2 during inflammation. Am J Med 1999;106:37S-42S.
6. Lefkowith JB. Cyclooxygenase-2 specificity and its clinical implications. Am J Med 1999;106:43S-50S.
7. Morton RS, Dongari-Bagdzoglou AI. Cyclooxygenase-2 is upregulated in inflamed gingival tissues. J Periodontol 2001;72:461-469.
8. Zhang F, Engebretson SP, Morton RS, Cavanaugh PF Jr, Subbaramaiah K, Dannenberg AJ. The overexpression of cyclo-oxygenase-2 in chronic periodontitis. J Am Dent Assoc 2003:134;861-867.
9. 2 secretion as a determinant of periodontal disease expression. J Periodontol 1993;64:432-444.
10. 2α upregulates interleukin-6 production in human gingival fibroblasts. J Periodontal Res 2001;36:80-87.
11. 2α in human gingival fibroblasts. J Periodontal Res 2001; 36:334-339.
12. Ohm K, Albers HK, Lisboa BP. Measurement of eight Prostaglandins in human gingival and periodontal disease using high pressure liquid chromatography and radioimmunoassay. J Periodontal Res 1984;19:501-511.
13. Offenbacher S, Odle BM, Braswell LD, et al. Changes in cyclooxygenase metabolites in experimental periodontitis in Macaca mulatta. J Periodontal Res 1989;24:63-74.
14. Bezerra MM, Lima V, Alencar VBM, et al. Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats. J Periodontol 2000; 71:1009-1014.
15. Holzhausen M, Rossa C Jr, Markantonio E Jr, Nassar PO, Spolidorio DMP, Spolidorio LC. Effect of selective cyclooxygenase-2 inhibition on development of ligature-induced periodontitis in rats. J Periodontol 2002:73;1030-1036.
16. 2α and clinical parameters of chronic periodontitis. J Periodontol 2003;74: 57-63.
17. Meghji S, Sandy JR, Scutt AM, Harvey W, Harris M. Stimulation of bone resorption by lipoxygenase metabolites of arachidonic acid. Prostaglandins 1988:36;139-149.
18. Campan P, Planchand P-O, Duran D. Pilot study on n-3 polyunsaturated fatty acids in the treatment of human experimental gingivitis. J Clin Periodontol 1997;24:907-913.
19. Croft KD, Sturm MJ, Codde JP, Vandongen R, Beilin LJ. Dietary fish oils reduce plasma levels of platelet activating factor precursor (lyso-PAF) in rats. Life Sci 1986; 38:1875-1882.
20. Braquet P, Touqui L, Shen TY, Vargaftig BB. Perspectives in platelet-activating factor research. Pharmacol Rev 1987;39:97-145.
21. Snyder F. Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. Am J Physiol 1990;259:C697-C708.
22. Ramamurthy NS, Golub LM, Gwinnett AJ, Salo T, Ding Y, Sorsa T. In vivo and in vitro inhibition of metalloproteinases including MMP-13 by several chemically modified tetracyclines (CMTs). In Davidovitch D, Mah J, eds Biologic Mechanisms of Tooth Eruption, Resorption and Replacement by Implants. Boston: Harvard Society for the Advancement of Orthodontics; 1998:271-277.
23. Powell WS. Reversed-phase high-pressure liquid chromatography of arachidonic acid metabolites formed by cyclooxygenase and lipoxygenases. Anal Biochem 1985; 148:59-69.
24. Tordjman C, Serkiz B, Rambaund F, Bonnet J, Volland JP. High-performance liquid chromatographic quantitation of cyclooxygenase and lipoxygenase metabolites of arachidonic acid from rat polymorphonuclear leukocytes. J Chromatogr 1990;532:135-143.
25. Offenbacher S. Periodontal diseases: Pathogenesis. Ann Periodontol 1996;1:821-878.
26. 4 in gingival crevicular fluid and gingival tissue in specific periodontal diseases. J Periodontol 2001;72:1025-1031.
27. Emingil G, Çinarcik S, Baylas H, Hüseyinov A. Levels of platelet-activating factor in gingival crevicular fluid and gingival tissue in specific periodontal diseases. J Periodontol 2001;72:1032-1037.
28. Vane JR, Botting RM. Mechanism of action of aspirin-like drugs. Semin Arthritis Rheum 1997;26:2-10.
29. Penning TD, Talley JJ, Bertenshaw SR, et al. Synthesis and biological evaluation the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: Identification of 4-[5-(4-methylphenil)-3-(trifluoromethyl)-1H-pyrazol-l-yl] bezenesulfonamide (SC-58635, celecoxib). J Med Chem 1997;40:1347-1365.
30. Hawkey CJ. COX-2 inhibitors. Lancet 1999;353:307-314.
31. Nieto N, Torres MI, Rios A, Gil A. Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis. J Nutr 2002;132:11-19.
32. Lasfargues JJ, Saffar JL. Effect of indomethacin on bone destruction during experimental periodontal disease in the hamster. J Periodontal Res 1983;18:110-117.
33. Heasman PA, Seymour RA. An association between long-term non-steroidal anti-inflammatory drug therapy and the severity of periodontal disease. J Clin Periodontol 1990;17:654-658.
34. Howell TH, Williams RC. Nonsteroidal anti-inflammatory drugs as inhibitors of periodontal disease progression. Crit Rev Oral Biol Med 1993;42:177-196.
35. Williams RC. Non-steroidal anti-inflammatory drugs for altering periodontal bone loss. J Dent Res 1999;78:638-642.
36. Spangler RS. Cycylooxygenase-1 and -2 in rheumatic disease: Implications for non-steroidal anti-inflammatory drug therapy. Semin Arthritis Rheum 1996;26:435-446.
37. Buduneli N, Vardar S, Atilla G, Sorsa T, Luoto H, Baylas H. Gingival crevicular fluid MMP-8 levels following adjunctive use of meloxicam and initial phase of periodontal treatment. J Periodontol 2002;73:103-109.
38. McMannus LM, Pickard RN. PAF, a putative mediator of oral inflammation. Crit Rev Oral Biol Med 2000;11:240-258.
39. Van der Merwe CF. A different and physiological approach to manipulating the inflammatory response. Eur J Gastroenterol Hepatol 1993;5:433-436.
40. 4 levels in gingiva and submandibular salivary glands of rats fed diet containing n-3 fatty acids. Lipids 1991;26:895-900.
41. Hotz G. Treatment of postoperative and post-traumatic edema using medicines (in German). ZWR 1986;95:256-261.
42. Croft KD, Beilin LJ, Loece FM, Vandongen R. Effects of diet enriched eicosapentaenoic or docosahexaenoic acid or prostanoid metabolism in the rat. Lipids 1987;22:647-650.